Add to Calendar 21st Oncology Updates: Advances and Controversies 1/17/2025 7:00:00 AM 1/20/2025 10:00:00 AM America/Chicago For More Details: https://mdanderson.cloud-cme.com/OncologyUpdates2025 Description: The treatment landscape for solid tumors is constantly evolving, and it's crucial for clinicians to stay updated on the latest advancements and therapeutic options. Many types of tumors now require a multidisciplinary approach, and therapies that were once reserved for advanced stages are increasingly being used in early, potentially curative stages. Healthcare professionals caring for cancer patients at vari... Steamboat Grand Hotel false MM/DD/YYYY


Date & Location
Friday, January 17, 2025, 7:00 AM - Monday, January 20, 2025, 10:00 AM, Steamboat Grand Hotel, Steamboat Springs, CO

Target Audience
Specialties - Colon and Rectal Surgery, Complex General Surgical Oncology, Gynecologic Oncology, Internal Medicine, Medical Oncology, Surgery, Thoracic Surgery, Urology
Professions - Other, Physician (MD or DO), Physician Associate

Credits
AMA PRA Category 1 Credits™ (19.50 hours), AAPA Category 1 CME (19.50 hours), ABS CC (19.50 hours), Medical Ethics/Professional Responsibility (2.25 hours), Non-Physician Attendance (19.50 hours)

Overview
The treatment landscape for solid tumors is constantly evolving, and it's crucial for clinicians to stay updated on the latest advancements and therapeutic options. Many types of tumors now require a multidisciplinary approach, and therapies that were once reserved for advanced stages are increasingly being used in early, potentially curative stages. Healthcare professionals caring for cancer patients at various stages need to grasp the foundational principles behind these therapies. Additionally, they must be adept at integrating both preclinical and clinical data into their everyday practice. This educational conference is designed to address the current challenges, updates, and innovative therapies for multiple tumor types through interactive sessions. It will bring together experts from various disciplines involved in the treatment of solid tumors. The goal is to facilitate the integration of new developments in cancer care into the clinical practice of surgeons, medical oncologists, radiation oncologists, and allied healthcare professionals. By attending, these professionals will be better equipped to provide the highest standard of care to their patients.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Effectively sequence surgical, radiation, and chemotherapy treatments for head and neck cancer, gastrointestinal cancers, melanoma, lung cancer, breast cancer, gynecologic cancers, and genitourinary cancers.
  2. Develop and apply optimal treatment plans for patients with varying disease stages, clinical presentations, and comorbidities, using real-world scenarios to ensure comprehensive and personalized care.
  3. Incorporate preventive measures, screening, and symptom management into oncology care to enhance early detection and improve the quality of life for patients across various cancer types.
  4. Identify patients who will appropriately benefit from novel therapies in the treatment of solid tumors.
  5. Utilize diverse surgical, radiation, and systemic treatments, including immunotherapies and molecular-targeted therapies, for cancers at various disease stages.

Registration
On-site registration for the 21st Annual Oncology Update: Advances and Controversies, will open at 6:30 AM on Friday, January 17, 2025, and the conference will begin at 7:00 AM  The conference will adjourn at 10:00 am on Monday, January 20, 2025.  Advanced registration is encouraged as space and materials are limited.  Please see registration form for applicable fees.

Advanced registration is encouraged. The deadline for advanced registration is January 3, 2025.

Registration Fees:

REGISTRATION CATEGORY

BEFORE JAN. 3

After JAN. 3

ON-SITE

Non-MD Anderson Faculty/Physicians/Scientists 

$700

$750

$800

MD Anderson Faculty/Physicians/Scientists

$650

$700

$800

Allied Healthcare Professionals 

$400

$450

$500

Oncology Update Guest Ticket (Meals Only)

$300

$350

$350

Felix Rutledge Alumni

$650

$700

$800

Felix Rutledge Guest Ticket (Meals Only)

$300

$350

$350

 

Telephone registrations are not accepted.


We accept the following forms of payment:
Credit Cards (MasterCard, VISA, and American Express)
Check (Payable to The University of Texas MD Anderson Cancer Center; through U.S. banks only)

Mail checks to:
   Continuing Professional Education (CPE) – Unit 1781
   The University of Texas MD Anderson Cancer Center
   P.O. Box 301407
   Houston, Texas 77230-1407

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on your profile during the process. 
 
Refund/Cancellation Policy
The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before January 3, 2025.  No refunds will be granted after this date.  The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. 

The Department of Continuing Professional Education (CPE) reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of the CPE is limited to the registration fee. CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in an activity and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Special Assistance or Additional Information
Contact Continuing Professional Education/Activity Management at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected].

Evaluation
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status.  Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics. 


Accreditation

Accreditation
In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 19.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 1.50 credit(s) of education in medical ethics and/or professional responsibility.

The University of Texas MD Anderson Cancer Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 19.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.





Additional Information

View the accessibility policy for The University of Texas MD Anderson Cancer Center.